A cooperation between the University of Bonn, the USA, and the Netherlands cracks the mode of action of clovibactin.
“Clovibactin is novel compared to current antibiotics in use,” says the co-spokesperson of the Transregional Collaborative Research Center “Antibiotic CellMAP,” who is also a member of the Transdisciplinary Research Area “Life & Health” and the Cluster of Excellence “ImmunoSensation2.” The Institute for Pharmaceutical Microbiology, together with the German Center for Infection Research, specializes in deciphering the mode of action of antibiotic candidates.
Prof. Dr. Tanja Schneider and her team from the Institute of Pharmaceutical Microbiology. Credit: Gregor Hübl/Uni Bonn
Technology Technology Latest News, Technology Technology Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: SciTechDaily1 - 🏆 84. / 68 Read more »
Source: SciTechDaily1 - 🏆 84. / 68 Read more »
Source: SciTechDaily1 - 🏆 84. / 68 Read more »